The cash flow of AbbVie Inc. over the past 10 years
Chart AbbVie Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, AbbVie Inc.'s operating cash flow was $19.03B and its capital expenditures $1.21B, leaving free cash flow of $17.82B. Free cash flow was above zero in all 10 years shown. It ranged from $6.56B in fiscal 2016 to $24.25B in fiscal 2022. Capital expenditures were highest in fiscal 2025, at $1.21B.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $19.03B | $1.21B | $17.82B |
| 2024ended Dec 31, 2024 | $18.81B | $974M | $17.83B |
| 2023ended Dec 31, 2023 | $22.84B | $777M | $22.06B |
| 2022ended Dec 31, 2022 | $24.94B | $695M | $24.25B |
| 2021ended Dec 31, 2021 | $22.78B | $787M | $21.99B |
| 2020ended Dec 31, 2020 | $17.59B | $798M | $16.79B |
| 2019ended Dec 31, 2019 | $13.32B | $552M | $12.77B |
| 2018ended Dec 31, 2018 | $13.43B | $638M | $12.79B |
| 2017ended Dec 31, 2017 | $9.96B | $529M | $9.43B |
| 2016ended Dec 31, 2016 | $7.04B | $479M | $6.56B |
Fiscal years as AbbVie Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AbbVie Inc.
- The revenue of AbbVie Inc.
- The profitability of AbbVie Inc.
- The debt of AbbVie Inc.
- The dividends of AbbVie Inc.
- All of AbbVie Inc.'s financials, charted
Companies of a similar size
- MAMastercard Incorporated
- PLTRPalantir Technologies Inc.
- ONCBEONE MEDICINES LTD.
- PDDPDD Holdings Inc.
- JNJJohnson & Johnson
Not investment advice. This page shows what AbbVie Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.